TrialThe journal of headache and pain2011

The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache.

Maria Antonova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.